CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy


Yildirim F. E., KARADUMAN A., PINAR A., AKSOY Y.

INTERNATIONAL JOURNAL OF DERMATOLOGY, vol.50, no.8, pp.948-955, 2011 (SCI-Expanded) identifier identifier identifier

Abstract

Objective The aim of this study is to determine serum levels of soluble forms of CD26/dipeptidyl-peptidase IV (DPP-IV) and adenosine deaminase (ADA), thought to be markers of T-cell activation, and changes in their levels in response to cyclosporine, etanercept, and psoralen plus ultraviolet A (PUVA) treatments with respect to disease activity.